Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The common autoimmune endocrinopathies result from an interaction between environmental factors and genetic predisposition. Several chromosomal gene regions have been shown to contribute to more than one disease, supporting the clinical observation that the autoimmune endocrine diseases cluster within individuals and families. Genetic studies have implicated the major histocompatability complex (MHC)-human leucocyte antigen (HLA) genes on chromosome 6p21, although this chromosomal region does not explain all of the genetic contribution to the various disorders. Non-MHC-HLA genes, including disease-specific loci, are beginning to be identified and the publication of the draft sequence of the human genome will undoubtedly expediate future discoveries. Combined with the establishment of large cohorts of subjects with disease and the development of technology capable of performing high-throughput genotyping, genetic studies are likely to impact on the future treatment and prevention of the common autoimmune endocrine diseases.

Type

Journal article

Journal

Clin Endocrinol (Oxf)

Publication Date

07/2003

Volume

59

Pages

1 - 11

Keywords

Antigens, CD, Antigens, Differentiation, Autoimmune Diseases, CTLA-4 Antigen, Chromosome Mapping, Endocrine System Diseases, Genes, MHC Class I, Genetic Linkage, Genetic Predisposition to Disease, Humans, Insulin, Receptors, Calcitriol, Receptors, Thyrotropin, Transcription Factors